{
    "eos9ei3": "# Synthetic accessibility score\n\nEstimation of synthetic accessibility score (SAScore) of drug-like molecules based on molecular complexity and fragment contributions. The fragment contributions are based on a 1M sample from PubChem and the molecular complexity is based on the presence/absence of non-standard structural features. It has been validated comparing the SAScore and the estimates of medicinal chemist experts for 40 molecules (r2 = 0.89). The SAScore has been contributed to the RDKit Package.\n\n## Identifiers\n\n* EOS model ID: `eos9ei3`\n* Slug: `sa-score`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Regression`\n* Output: `Score`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: Low scores indicate higher synthetic accessibility\n\n## References\n\n* [Publication](https://jcheminf.biomedcentral.com/articles/10.1186/1758-2946-1-8)\n* [Source Code](https://github.com/rdkit/rdkit/tree/master/Contrib/SA_Score)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos9ei3)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos9ei3.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos9ei3) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://jcheminf.biomedcentral.com/articles/10.1186/1758-2946-1-8) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a BSD-3.0 license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos9yui": "# Natural product likeness score\n\nThe model is a derivation of the natural product fingerprint (eos6tg8). In addition to generating specific natural product fingerprints, the activation value of the neuron that predicts if a molecule is a natural product or not can be used as a NP-likeness score. The method outperforms the NP\\_Score implemented in RDKit.\n\n## Identifiers\n\n* EOS model ID: `eos9yui`\n* Slug: `natural-product-likeness`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Regression`\n* Output: `Score`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: Higher score indicates higher natural product likeness\n\n## References\n\n* [Publication](https://www.sciencedirect.com/science/article/pii/S2001037021003226?)\n* [Source Code](https://github.com/kochgroup/neural_npfp)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos9yui)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos9yui.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos9yui) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://www.sciencedirect.com/science/article/pii/S2001037021003226?) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a None license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos2r5a": "# Retrosynthetic accessibility score\n\nRetrosynthetic accessibility score based on the computer aided synthesis planning tool AiZynthfinder. The authors have selected a ChEMBL subset of 200.000 molecules, and checked whether AiZinthFinder could identify a synthetic route or not. This data has been trained to create a classifier that computes 4500 times faster than the underlying AiZynthFinder. Molecules outside the applicability domain, such as the GBD database, need to be fine tuned to their use case.\n\n## Identifiers\n\n* EOS model ID: `eos2r5a`\n* Slug: `retrosynthetic-accessibility`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Regression`\n* Output: `Score`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: Higher score indicates easier retrosynthetic accessibility\n\n## References\n\n* [Publication](https://pubs.rsc.org/en/content/articlelanding/2021/sc/d0sc05401a)\n* [Source Code](https://github.com/reymond-group/RAscore)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos2r5a)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos2r5a.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos2r5a) (AMD64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://pubs.rsc.org/en/content/articlelanding/2021/sc/d0sc05401a) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a MIT license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos4djh": "# Basic molecular descriptors from Datamol\n\nBasic molecular descriptors calculated with the Datamol package, including molecular weight, lipophilicity (cLogP), hydrogen bond donnors, hydrogen bond acceptors, etc. These descriptors are generally useful to annotate small molecule libraries. They are not recommended for QSAR modeling since they are probably too simple for most scenarios.\n\n## Identifiers\n\n* EOS model ID: `eos4djh`\n* Slug: `datamol-basic-descriptors`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Representation`\n* Output: `Descriptor`\n* Output Type: `Float, Integer`\n* Output Shape: `List`\n* Interpretation: Basic molecular descriptors. Some descriptors are floats and some are counts.\n\n## References\n\n* [Publication](https://github.com/datamol-io/datamol)\n* [Source Code](https://docs.datamol.io/0.7.4/api/datamol.descriptors.html)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos4djh)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos4djh.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos4djh) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://github.com/datamol-io/datamol) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a Apache-2.0 license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos7d58": "# ADMET properties prediction\n\nA framework based on ensemble of five Chemprop-RDKit models, for fast batch prediction of ADMET properties of small molecules. The framework exists as a CLI tool, a Python API, and a web server. We incorporate it using the API.\n\n## Identifiers\n\n* EOS model ID: `eos7d58`\n* Slug: `admet-ai-prediction`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Classification, Regression`\n* Output: `Probability, Score`\n* Output Type: `Float`\n* Output Shape: `List`\n* Interpretation: ADMET AI is a framework for carrying out fast batch predictions for ADMET properties. It is based on ensemble of five Chemprop-RDKit models and has been trained on 41 tasks from the ADMET group in Therapeutics Data Commons (v0.4.1). Out of these 41 tasks, there are 31 classification tasks and 10 regression tasks. In addition to that output also contains 8 physicochemical properties, namely, molecular weight, logP, hydrogen bond acceptors, hydrogen bond doners, Lipinski's Rule of 5, QED, stereo centers, and topological polar surface area. Furthermore, each of these outcomes is contextualized through a computation of its percentile in reference to DrugBank approved drugs. According to the authors, the framework can generate predicitons for a million compounds in approximately 3 hours on a single GPU or 32 CPU machine.\n\n## References\n\n* [Publication](https://www.biorxiv.org/content/10.1101/2023.12.28.573531v1)\n* [Source Code](https://github.com/swansonk14/admet_ai)\n* Ersilia contributor: [DhanshreeA](https://github.com/DhanshreeA)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos7d58)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos7d58.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos7d58) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://www.biorxiv.org/content/10.1101/2023.12.28.573531v1) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a MIT license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos2ta5": "# Ligand-based prediction of hERG blockade\n\nA robust predictor for hERG channel blockade based on an ensemble of five deep learning models. The authors have collected a dataset from public sources, such as BindingDB and ChEMBL on hERG blockers and non-blockers. The cut-off for hERG blockade was set at IC50 < 10 uM for the classifier.\n\n## Identifiers\n\n* EOS model ID: `eos2ta5`\n* Slug: `cardiotoxnet-herg`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Classification`\n* Output: `Probability`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: Probability that the compound inhibits hERG (IC50 < 10 uM)\n\n## References\n\n* [Publication](https://jcheminf.biomedcentral.com/articles/10.1186/s13321-021-00541-z)\n* [Source Code](https://github.com/Abdulk084/CardioTox)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos2ta5)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos2ta5.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos2ta5) (AMD64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://jcheminf.biomedcentral.com/articles/10.1186/s13321-021-00541-z) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a None license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos8fth": "# SARS-CoV-2 antiviral prediction: REDIAL-2020\n\nPredictor of several endpoints related to Sars-CoV-2. It provides predictions for Live Virus Infectivity, Viral Entry, Viral Replication, In Vitro Infectivity and Human Cell Toxicity using a combination of three models. Consensus results are obtained by averaging the prediction for the three different models for each activity and toxicity models. The models have been built using NCATS COVID19 data. Further details on result interpretations can be found here: https://drugcentral.org/Redial\n\n## Identifiers\n\n* EOS model ID: `eos8fth`\n* Slug: `redial-2020`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Classification`\n* Output: `Probability`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: The model returns the probability of 1 (active) in each assay. Good drugs are active in CPE, 3CL and are inactive in cytotox, hCYTOX and ACE2 and/or are active in at least one of the following: AlphaLISA, CoV-PPE, MERS-PPE, while inactive in the counter screen, respectively: TruHit, CoV-PPE_cs, MERS-PPE_cs.\n\n## References\n\n* [Publication](https://www.nature.com/articles/s42256-021-00335-w#Sec9)\n* [Source Code](https://github.com/sirimullalab/redial-2020/tree/v1.0)\n* Ersilia contributor: [Pradnya2203](https://github.com/Pradnya2203)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos8fth)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos8fth.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos8fth) (AMD64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://www.nature.com/articles/s42256-021-00335-w#Sec9) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a MIT license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos9f6t": "# SARS-CoV inhibition\n\nThis model was developed to support the early efforts in the identification of novel drugs against SARS-CoV2. It predicts the probability that a small molecule inhibits SARS-3CLpro-mediated peptide cleavage. It was developed using a high-throughput screening against the 3CL protease of SARS-CoV1, as no data was yet available for the new virus (SARS-CoV2) causing the COVID-19 pandemic. It uses the ChemProp model.\n\n## Identifiers\n\n* EOS model ID: `eos9f6t`\n* Slug: `chemprop-sars-cov-inhibition`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Classification`\n* Output: `Probability`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: Probability of 3CL protease inhibition (%) The classifier was trained using a threshold of 12% of inhibition \n\n## References\n\n* [Publication](https://www.sciencedirect.com/science/article/pii/S0092867420301021)\n* [Source Code](http://chemprop.csail.mit.edu/checkpoints)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos9f6t)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos9f6t.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos9f6t) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://www.sciencedirect.com/science/article/pii/S0092867420301021) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a MIT license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos3nn9": "# Predict bioactivity against Main Protease of SARS-CoV-2\n\nMProPred predicts the efficacy of compounds against the main protease of SARS-CoV-2, which is a promising drug target since it processes polyproteins of SARS-CoV-2. This model uses PaDEL-Descriptor to calculate molecular descriptors of compounds. It is based on a dataset of 758 compounds that have inhibition efficacy against the Main Protease, as published in peer-reviewed journals between January, 2020 and August, 2021. Input compounds are compared to compounds in the dataset to measure molecular similarity with MACCS.\n\n## Identifiers\n\n* EOS model ID: `eos3nn9`\n* Slug: `mpro-covid19`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Regression`\n* Output: `Score`\n* Output Type: `Float`\n* Output Shape: `List`\n* Interpretation: Gives the pIC50 values for each compound to compare their bioactivity against the main protease\n\n## References\n\n* [Publication](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289339/)\n* [Source Code](https://github.com/Nadimfrds/Mpropred)\n* Ersilia contributor: [HarmonySosa](https://github.com/HarmonySosa)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos3nn9)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos3nn9.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos3nn9) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289339/) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a MIT license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos4e40": "# Broad spectrum antibiotic activity\n\nBased on a simple E.coli growth inhibition assay, the authors trained a model capable of identifying antibiotic potential in compounds structurally divergent from conventional antibiotic drugs. One of the predicted active molecules, Halicin (SU3327), was experimentally validated in vitro and in vivo. Halicin is a drug under development as a treatment for diabetes.\n\n## Identifiers\n\n* EOS model ID: `eos4e40`\n* Slug: `chemprop-antibiotic`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Classification`\n* Output: `Probability`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: Probability that a compound inhibits E.coli growth. The inhibition threshold was set at 80% growth inhibition in the training set.\n\n## References\n\n* [Publication](https://pubmed.ncbi.nlm.nih.gov/32084340/)\n* [Source Code](http://chemprop.csail.mit.edu/checkpoints)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos4e40)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos4e40.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos4e40) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://pubmed.ncbi.nlm.nih.gov/32084340/) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a MIT license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos7kpb": "# H3D virtual screening cascade light\n\nThis panel of models provides predictions for the H3D virtual screening cascade. It leverages the Ersilia Compound Embedding and FLAML. The H3D virtual screening cascade contains models for Mycobacterium tuberculosis and Plasmodium falciparum IC50 predictions, as well as ADME, cytotoxicity and solubility assays\n\n## Identifiers\n\n* EOS model ID: `eos7kpb`\n* Slug: `h3d-virtual-screening-cascade-light`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Classification`\n* Output: `Probability`\n* Output Type: `Float`\n* Output Shape: `List`\n* Interpretation: The raw scores are the ones emerging from the FLAML model. The ones with a sufix _perc represent the percentile in the scale 0-1 over a ChEMBL dataset of 200k compounds.\n\n## References\n\n* [Publication](https://www.nature.com/articles/s41467-023-41512-2)\n* [Source Code](https://github.com/ersilia-os/h3d-screening-cascade-models)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos7kpb)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos7kpb.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos7kpb) (AMD64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://www.nature.com/articles/s41467-023-41512-2) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a GPL-3.0 license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos4zfy": "# MAIP: antimalarial activity prediction\n\nPrediction of the antimalarial potential of small molecules. This model is an ensemble of smaller QSAR models trained on proprietary data from various sources, up to a total of >7M compounds. The training sets belong to Evotec, Johns Hopkins, MRCT, MMV - St. Jude, AZ, GSK, and St. Jude Vendor Library. The code and training data are not released, using this model posts predictions to the MAIP online server. The Ersilia Model Hub also offers MAIP-surrogate as a downloadable package for IP-sensitive queries.\n\n## Identifiers\n\n* EOS model ID: `eos4zfy`\n* Slug: `maip-malaria`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Classification`\n* Output: `Score`\n* Output Type: `Float`\n* Output Shape: `Single`\n* Interpretation: Higher score indicates higher antimalarial potential\n\n## References\n\n* [Publication](https://jcheminf.biomedcentral.com/articles/10.1186/s13321-021-00487-2)\n* [Source Code](https://www.ebi.ac.uk/chembl/maip/)\n* Ersilia contributor: [Amna-28](https://github.com/Amna-28)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos4zfy)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos4zfy.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos4zfy) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://jcheminf.biomedcentral.com/articles/10.1186/s13321-021-00487-2) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a None license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!",
    "eos9gg2": "# Chemical space 2D projections against DrugBank\n\nThis tool performs PCA, UMAP and tSNE projections taking the DrugBank chemical space as a reference. The Ersilia Compound Embeddings as used as descriptors. Four PCA components and two UMAP and tSNE components are returned.\n\n## Identifiers\n\n* EOS model ID: `eos9gg2`\n* Slug: `chemical-space-projections-drugbank`\n\n## Characteristics\n\n* Input: `Compound`\n* Input Shape: `Single`\n* Task: `Representation`\n* Output: `Descriptor`\n* Output Type: `Float`\n* Output Shape: `List`\n* Interpretation: Coordinates of 2D projections, namely PCA, UMAP and tSNE.\n\n## References\n\n* [Publication](https://academic.oup.com/nar/article/52/D1/D1265/7416367)\n* [Source Code](https://github.com/ersilia-os/compound-embedding)\n* Ersilia contributor: [miquelduranfrigola](https://github.com/miquelduranfrigola)\n\n## Ersilia model URLs\n* [GitHub](https://github.com/ersilia-os/eos9gg2)\n* [AWS S3](https://ersilia-models-zipped.s3.eu-central-1.amazonaws.com/eos9gg2.zip)\n* [DockerHub](https://hub.docker.com/r/ersiliaos/eos9gg2) (AMD64, ARM64)\n\n## Citation\n\nIf you use this model, please cite the [original authors](https://academic.oup.com/nar/article/52/D1/D1265/7416367) of the model and the [Ersilia Model Hub](https://github.com/ersilia-os/ersilia/blob/master/CITATION.cff).\n\n## License\n\nThis package is licensed under a GPL-3.0 license. The model contained within this package is licensed under a GPL-3.0-or-later license.\n\nNotice: Ersilia grants access to these models 'as is' provided by the original authors, please refer to the original code repository and/or publication if you use the model in your research.\n\n## About Us\n\nThe [Ersilia Open Source Initiative](https://ersilia.io) is a Non Profit Organization ([1192266](https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5170657/full-print)) with the mission is to equip labs, universities and clinics in LMIC with AI/ML tools for infectious disease research.\n\n[Help us](https://www.ersilia.io/donate) achieve our mission!"
}